YOGARAJAH BALARAJAN, MD
700 SHADOW LN SUITE 240, LAS VEGAS, NV 89106
NPI Number
1639168982
Practice location · View on Google Maps
Total Medicaid Payments
$73,803
-80% vs specialty average
Patients Seen
2,242
Total Claims
2,432
$ Per Patient
$33
Specialty avg: $35
Specialty Rank
#23 of 93
Internal Medicine, Cardiovascular Disease providers in Nevada
Peer Average
$369,495
Average total for Internal Medicine, Cardiovascular Disease
Claims per Patient
1.1
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $73,803 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 93306 | Heart ultrasound (echocardiogram) | 359 | $37,578 | 50.9% | $105 |
| 99204 | New patient office visit — detailed visit for a serious problem | 91 | $13,240 | 17.9% | $145 |
| 93010 | Heart monitoring test (ECG/EKG) | 1,584 | $10,938 | 14.8% | $7 |
| 99214 | Office visit for a moderate problem (established patient) | 67 | $5,431 | 7.4% | $81 |
| 93015 | Heart monitoring test (ECG/EKG) | 44 | $2,787 | 3.8% | $63 |
| 99222 | Hospital admission — first day, moderate to serious problem | 14 | $1,271 | 1.7% | $91 |
| 93000 | Heart monitoring test (ECG/EKG) | 92 | $1,255 | 1.7% | $14 |
| 93042 | Heart monitoring test (ECG/EKG) | 107 | $553 | 0.7% | $5 |
| 93040 | Heart monitoring test (ECG/EKG) | 44 | $413 | 0.6% | $9 |
| 93018 | Heart monitoring test (ECG/EKG) | 30 | $336 | 0.5% | $11 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.